Contrarily, several research groups have observed that higher expression of MARCKS inhibits cancer development and progression in colorectal cancer [110, 147], hepatocellular carcinoma [148], melanoma [149], and glioma [12, 105, 150]. The gene discussed is MARCKS; the disease is central nervous system cancer.